Drugs / DELPARANTAG
DELPARANTAG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01312935 | Apr 2011 → Jun 2012 | coronary artery disorder | PolyMedix, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DELPARANTAG | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107820 ↗ |
| Known as | PMX-60056 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01312935 ↗ |
| Known as | Pmx60056, pmx-60056, pmx 60056 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107820 ↗ |
| Modality | Small molecule | — CHEMBL2107820 ↗ |